Normal Human Epidermal Keratinocytes

Normal Human Epidermal Keratinocytes

Cat.No.: CSC-C4071X

Species: Human

Source: Epidermis; Skin

Cell Type: Keratinocyte

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4071X
Description
Creative Bioarray's normal Human Epidermal Keratinocytes (HEK), when grown in Creative Bioarray's LIDer K Medium, provide an ideal serum-free culture model, for the study of wound healing, toxicology or epithelial biology. When in need of multiple keratinocyte cell lots, our HEK, 10-donor pool offers a wide range of donor demographics for research at an economical price. All HEK are quality tested in LIDer K Medium to ensure optimal serum-free growth over a period of at least 15 population doublings at rates equal to or greater than serum-supplemented medium. Our HEK need not be exposed to antimicrobials or phenol red when cultured in LIDer medium; an advantage since these supplements can cause cell stress and "masking effects" that may negatively impact experimental result.

Cell Features:
HEKn are cryopreserved as primary cells. Cells are isolated from neonatal human foreskin and expanded once in culture vessels before cryopreservation.
HEKa are cryopreserved as primary cells. Cells are isolated from adult human skin and expanded once in culture vessels before cryopreservation.
HEK can be grown without serum, phenol red or antimicrobials when cultured in DermaLife medium.
HEK are extensively tested for quality and optimal performance.
Creative Bioarray guarantees performance and quality.
Species
Human
Source
Epidermis; Skin
Cell Type
Keratinocyte
Disease
Normal
Storage and Shipping
Store in liquid nitrogen and ship in dry ice.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Normal human epidermal keratinocytes (NHEKs) are primary keratinocytes isolated from normal human skin, typically neonatal or adult epidermis. They retain basal markers p63 and cytokeratin 5/14 and, upon differentiation, express cytokeratin 1/10, involucrin, filaggrin, and loricrin. In low-calcium serum-free medium, NHEKs maintain a proliferative basal phenotype; calcium switch or air-liquid interface culture induces terminal differentiation, stratified epidermal architecture, cornified envelope formation, and barrier development. This enables functional studies of epidermal homeostasis, barrier integrity, innate immune signaling, and cutaneous inflammation.

Compared with immortalized keratinocyte lines such as HaCaT, NHEKs better preserve donor genetic background, native receptor expression, and physiological signaling. They are more human-relevant than animal keratinocytes for dermatological research. NHEKs are widely used to model wound healing, psoriasis, atopic dermatitis, contact dermatitis, photoaging, and skin carcinogenesis, and to evaluate drugs, cosmetics, irritants, sensitizers, and wound-care products. They are compatible with monolayer culture, 3D organotypic skin equivalents, and co-culture with fibroblasts, melanocytes, or immune cells.

Overall, NHEKs provide a robust, human-relevant, and physiologically characterized platform for cutaneous biology, disease modeling, safety assessment, and translational dermatological research.

Effects of Betulinic Acid and Ursolic Acid on IL-17-Induced CCL20 Release in Normal Human Epidermal Keratinocytes

Psoriasis is a chronic inflammatory skin disease characterized by erythema, infiltration, and scaling, which is mainly caused by interleukin (IL)-17. The use of molecular targeted drugs in specific therapies offers high efficacy; however, high medical costs and a significant risk of side effects highlight the need for novel therapeutic agents. We previously observed that Morus alba extract (MAE) suppressed IL-17-induced CCL20 mRNA expression in normal human epidermal keratinocytes (NHEKs). In this study, we focused on the IL-17 signaling pathway and investigated the effects of pentacyclic triterpenoids, betulinic acid (BA), and ursolic acid (UA), which are present in MAE, on NHEK cells. Real-time reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) revealed that both BA and UA suppressed CCL20 expression, while only UA alone inhibited CCL20 release. ELISA using specific inhibitors demonstrated that both the p38 and extracellular-signal-regulated kinase 1/2 (ERK1/2) pathways were crucial for IL-17-induced CCL20 release in NHEK. UA effectively suppressed ERK1/2 nuclear localization and moderately affected p38 phosphorylation. These results indicated that UA is a potential seed compound for psoriasis treatment through its targeting of the IL-17 pathway.

Effects of BA and UA on IL-17-Induced CCL20 Expression and Release.
Fig. 1. Effects of BA and UA on IL-17-induced expression and release of CCL20 (Arai, Anna, et al., 2025).
Effects of BA and UA on IL-17-Induced ERK1/2 Nuclear Localization.
Fig. 2. Effects of betulinic acid (BA) and ursolic acid (UA) on IL-17-induced nuclear localization of ERK1/2 and C/EBPβ (Arai, Anna, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products